Digital AI scientists and the robotic labs of tomorrow AI scientists will no longer operate at the margins of life sciences research - they'll become essential collaborators in the labs of tomorrow.
Sales & Marketing Sponsored 5 forces reshaping pharma commercialisation in 2026 As infrastructure bottlenecks ease and regulatory frameworks mature, pharma's AI adoption is shifting from proof-of-concept to production-grade deployment
Digital The evolution of leadership for healthcare organisations in ... Leaders must be adaptive, forward-thinking, and equipped to cultivate environments where humans and AI work together effectively and ethically.
Digital The role of AI technologies in precision oncology By focusing on assistance to the front-line oncologist, AI can enable improved diagnosis, clinical trials, and timely, accurate decision making.
Digital Agentic AI: The shift from R&D to R&P will deliver the first... The next two years will be defined by a shift from R&D (Research & Development) to R&P (Research & Prediction), facilitated by agentic AI.
Digital Beyond regulation: 4 AI trends transforming life sciences te... Artificial intelligence (AI) is becoming embedded into the fabric of quality, compliance, and production systems.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.